Tim Harris > Osborne Clarke LLP > London, England > Lawyer Profile

Continuing to expand its patent practice, the ‘switched on and collaborative’ team at Osborne Clarke LLP counts notable biotech and pharmaceutical clients among its key roster of clients, handling revocation and infringement proceedings on a global scale alongside technical commercial transactional mandates. Arty Rajendra heads up the group, fielding a strong practice on the SEP and FRAND disputes side, while Will James possesses a wealth of experience across the life sciences, electronics, and medical device sectors. Tim Harris drives life sciences, pharmaceutical, and biotech mandates for the team, and Trevor Crosse utilises his background in microbiology and immunology to handle blockbuster drugs and other technically complex products.

A range of multinational biopharmaceutical and medical device companies turn to Osborne Clarke LLP for assistance with work such as multi-jurisdictional patent litigation, life sciences M&A and financing transactions. A foursome of partners oversee the team: Will James‘ contentious IP expertise has seen him litigate before the UK courts and the UPC. Matthew Edwards is praised for his ‘smooth and successful’ handling of transactions. His corporate expertise is relied upon by the likes of BioNtech. Marcus Vass is well-versed in the digital health sector, and Richard Wilkinson heads up the firm’s healthcare subsector. Tim Harris is a further key contact and extends the unit’s international IP litigation strength.